Article
Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology - 1 Mar 2015
Midde Narasimha M, Yuan Yaxia, Quizon Pamela M, Sun Wei-Lun, Huang Xiaoqin, Zhan Chang-Guo, Zhu Jun
Abstract excerpt
HIV-1 transactivator of transcription (Tat) protein disrupts the dopamine (DA) neurotransmission by inhibiting DA transporter (DAT) function, leading to increased neurocognitive impairment in HIV-1 infected individuals. Through integrated computational modeling and pharmacological studies, we have demonstrated that mutation of tyrosine470 (Y470H) of human DAT (hDAT) attenuates Tat-induced inhibition of DA uptake...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
